Royalty Pharma plc
RPRX
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profitsā¦ read more
Healthcare
Biotechnology
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$47.97
Price+3.45%
$1.60
1Y
Price
Market Cap
$20.552b
Large
Price/Earnings 3y Avg5y Avg
27x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+72.6%
EBITDA Margin+34.4%
Net Profit Margin+133.0%
Free Cash Flow Margin+72.6%
EBITDA Margin+34.4%
Net Profit Margin+133.0%
Free Cash Flow MarginRevenue
$2.378b
+5.1%
1y CAGR+2.2%
3y CAGR+1.0%
5y CAGREarnings
$770.947m
-10.2%
1y CAGR+838.3%
3y CAGR+605.5%
5y CAGREPS
$1.80
+23.5%
1y CAGR+803.6%
3y CAGR+579.4%
5y CAGRBook Value
$9.715b
$19.621b
Assets$9.906b
Liabilities$8.951b
DebtDebt to Assets
45.6%
5.5x
Debt to EBITDAFree Cash Flow
$2.490b
-10.1%
1y CAGR+7.3%
3y CAGR+7.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company